A detailed history of Rubric Capital Management LP transactions in Ardelyx, Inc. stock. As of the latest transaction made, Rubric Capital Management LP holds 3,060,191 shares of ARDX stock, worth $14.7 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
3,060,191
Previous 1,816,585 68.46%
Holding current value
$14.7 Million
Previous $13.5 Million 56.64%
% of portfolio
0.59%
Previous 0.4%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.28 - $7.57 $6.57 Million - $9.41 Million
1,243,606 Added 68.46%
3,060,191 $21.1 Million
Q1 2024

May 10, 2024

SELL
$6.05 - $9.74 $13.3 Million - $21.4 Million
-2,196,168 Reduced 54.73%
1,816,585 $13.3 Million
Q4 2023

Feb 13, 2024

BUY
$3.29 - $6.64 $4.98 Million - $10 Million
1,512,753 Added 60.51%
4,012,753 $24.9 Million
Q3 2023

Nov 14, 2023

BUY
$3.3 - $4.83 $8.25 Million - $12.1 Million
2,500,000 New
2,500,000 $10.2 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $742M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.